DIVISLAB.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (9 May 2024 @ 05:59):

Stats
Today's Volume	626 161
Average Volume	540 626
Market Cap	1 006.11B
EPS	INR0 ( 2024-02-10 )
Next earnings date	( INR0 ) 2024-05-17
Last Dividend	INR30.00 ( 2023-08-10 )
Next Dividend	INR0 ( N/A )
P/E	72.86
ATR14	INR5.25 (0.14%)

Volume Correlation

Long: 0.36 (neutral)

Short: 0.40 (neutral)

Signal:(51.551) Neutral

Divi's Laboratories Correlation

10 Most Positive Correlations
KHAICHEM.NS	0.898
STAR.NS	0.897
20MICRONS.NS	0.891
IGPL.NS	0.872
HIL.NS	0.871
SANGHIIND.NS	0.865
DBREALTY.NS	0.864
AYMSYNTEX.NS	0.863
GRANULES.NS	0.857
KUANTUM.NS	0.857

10 Most Negative Correlations
RAJRILTD.NS	-0.879
PERSISTENT.NS	-0.846
GNA.NS	-0.83
GTNIND.NS	-0.829
4THDIM.NS	-0.824
LTGILTBEES.NS	-0.824
SRTRANSFIN.NS	-0.82
ACI.NS	-0.819
ICICIBANKN.NS	-0.81
RADICO.NS	-0.801

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Divi's Laboratories Correlation - Currency/Commodity

0.69
( moderate )

0.27
( neutral )

0.69
( moderate )

0.39
( neutral )

-0.44
( neutral )

-0.63
( weak negative )

Divi's Laboratories Financials

Annual	2022
Revenue:	INR77.68B
Gross Profit:	INR47.14B (60.69 %)
EPS:	INR68.69

FY	2022
Revenue:	INR77.68B
Gross Profit:	INR47.14B (60.69 %)
EPS:	INR68.69

FY	2022
Revenue:	INR87.99B
Gross Profit:	INR58.32B (66.28 %)
EPS:	INR111.52

FY	2021
Revenue:	INR68.58B
Gross Profit:	INR45.34B (66.11 %)
EPS:	INR74.75

Financial Reports:

No articles found.

Divi's Laboratories Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR30.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR30.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Divi's Laboratories Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.40 - low (13.17%) | Divividend Growth Potential Score: 3.54 - Decrease likely (29.11%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR0.300	2003-08-11
Last Dividend	INR30.00	2023-08-10
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	21	--
Total Paid Out	INR188.60	--
Avg. Dividend % Per Year	0.49%	--
Score	1.95	--
Div. Sustainability Score	3.40
Div.Growth Potential Score	3.54
Div. Directional Score	3.47	--

Next Divdend (Est)
(2024-06-27)

INR32.66 Estimate 3.12 %

Dividend Stability

0.25 Very Poor

Dividend Score

1.95

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR10.00	0.83%
2019	INR16.00	1.08%
2020	INR16.00	0.88%
2021	INR20.00	0.52%
2022	INR30.00	0.65%
2023	INR30.00	0.89%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
RAILTEL.NS	Dividend Junior	2023-08-24	Semi-Annually	4	1.19%
KHAICHEM.NS	No Dividend Player	2023-07-21	Annually	5	0.32%
EMAMIPAP.NS	Dividend Junior	2023-09-05	Annually	3	0.56%
AJANTPHARM.NS	Dividend Knight	2023-08-04	Annually	23	0.57%
SUPRAJIT.NS	Dividend Junior	2023-09-18	Semi-Annually	20	0.45%
NAVNETEDUL.NS	Dividend Junior	2023-08-07	Annually	22	1.10%
HPIL.NS	Dividend Junior	2023-09-29	Annually	5	0.89%
CARERATING.NS	Dividend Knight	2023-07-06	Semi-Annually	12	1.81%
ROUTE.NS	Dividend Knight	2023-09-06	Semi-Annually	4	0.38%
LFIC.NS	Dividend Junior	2023-08-01	Annually	15	1.73%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.185	1.500	6.30	9.44	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.109	1.500	9.90	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	1 546.55	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	27.88	2.00	0.708	1.416	[0 - 30]
freeCashFlowPerShareTTM	27.88	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.592	1.000	3.46	3.46	[0.2 - 0.8]
operatingProfitMarginTTM	0.256	1.000	6.88	6.88	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.40

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	73.84	1.000	2.64	0	[1 - 100]
returnOnEquityTTM	0.109	2.50	9.94	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	27.88	2.00	0.708	10.00	[0 - 30]
dividendYielPercentageTTM	0.777	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	27.88	2.00	0.708	1.416	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	3.08	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0988	1.000	-0.0308	0	[0.1 - 0.5]
Total Score				3.54

Divi's Laboratories

Divi's Laboratories Limited manufactures and sells generic active pharmaceutical ingredients (APIs) and intermediates, and nutraceutical ingredients in India, the United States, Asia, Europe, and internationally. It also undertakes custom synthesis of APIs and intermediates; and supplies a range of carotenoids, as well as markets vitamins to nutritional, pharma, food/beverage, and feed industries. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. The company was incorporated in 1990 and is headquartered in Hyderabad, India.